MDXG Q1 2020 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$62M-7.2% YoY

Gross Profit

$52M83.8% margin

Operating Income

-$14M-22.3% margin

Net Income

-$5M-7.8% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

-19.2%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$159M

Total Liabilities

$129M

Stockholders' Equity

$30M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$62M	$67M	-7.2%
Gross Profit	$52M	$59M	-12.6%
Operating Income	-$14M	-$13M	-2.5%
Net Income	-$5M	-$13M	+63.7%